05/09/2024
6:05 AM | Amylyx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
6:12 AM | Amylyx Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/24/2024
6:12 AM | Amylyx Pharmaceuticals (Filer)
| Form DEFA14A | |
04/24/2024
6:19 AM | Amylyx Pharmaceuticals (Filer)
| Form ARS | |
04/24/2024
6:07 AM | Amylyx Pharmaceuticals (Filer)
| Form DEF 14A | |
04/18/2024
7:19 PM | Amylyx Pharmaceuticals (Issuer)
Bedrosian Camille L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/18/2024
7:20 PM | Amylyx Pharmaceuticals (Issuer)
Klee Justin B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
04/18/2024
7:20 PM | Amylyx Pharmaceuticals (Issuer)
Mazzariello Gina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/18/2024
7:21 PM | Amylyx Pharmaceuticals (Issuer)
Cohen Joshua B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/18/2024
7:23 PM | Amylyx Pharmaceuticals (Issuer)
FRATES JAMES M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
8:19 AM | Amylyx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/04/2024
6:10 AM | Amylyx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/15/2024
3:31 PM | Amylyx Pharmaceuticals (Issuer)
Zeiher Bernhardt G (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/15/2024
3:35 PM | Amylyx Pharmaceuticals (Issuer)
Zeiher Bernhardt G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2024
8:18 AM | Amylyx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/11/2024
7:44 AM | Amylyx Pharmaceuticals (Subject)
Panacea Innovation Ltd (Filed by)
| Form SC 13G | |
03/08/2024
6:10 AM | Amylyx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/28/2024
5:44 PM | Amylyx Pharmaceuticals (Issuer)
FRATES JAMES M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
5:13 PM | Amylyx Pharmaceuticals (Issuer)
Mazzariello Gina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
5:20 PM | Amylyx Pharmaceuticals (Issuer)
Klee Justin B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
5:22 PM | Amylyx Pharmaceuticals (Issuer)
Cohen Joshua B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
7:22 AM | Amylyx Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/22/2024
6:08 AM | Amylyx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
3:36 PM | Amylyx Pharmaceuticals (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
| Form SC 13G/A | |
02/14/2024
9:24 AM | Amylyx Pharmaceuticals (Subject)
VIKING GLOBAL INVESTORS LP (Filed by)
| Form SC 13G/A | |
02/14/2024
6:15 AM | Amylyx Pharmaceuticals (Subject)
Point72 Asset Management, L.P. (Filed by)
| Form SC 13G/A | |
01/29/2024
4:25 PM | Amylyx Pharmaceuticals (Subject)
BlackRock Inc. (Filed by)
| Form SC 13G | |
01/29/2024
3:38 PM | Amylyx Pharmaceuticals (Issuer)
MILNE GEORGE M JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/18/2024
3:50 PM | Amylyx Pharmaceuticals (Issuer)
MILNE GEORGE M JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/11/2024
4:04 PM | Amylyx Pharmaceuticals (Issuer)
Yeramian Patrick D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/11/2024
4:10 PM | Amylyx Pharmaceuticals (Issuer)
Cohen Joshua B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/11/2024
4:11 PM | Amylyx Pharmaceuticals (Issuer)
FRATES JAMES M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/11/2024
4:11 PM | Amylyx Pharmaceuticals (Issuer)
Klee Justin B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2023
3:37 PM | Amylyx Pharmaceuticals (Issuer)
Firestone Karen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/07/2023
6:00 AM | Amylyx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/29/2023
3:45 PM | Amylyx Pharmaceuticals (Issuer)
Bedrosian Camille L (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/29/2023
3:49 PM | Amylyx Pharmaceuticals (Issuer)
Bedrosian Camille L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2023
7:20 PM | Amylyx Pharmaceuticals (Issuer)
Cohen Joshua B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/09/2023
5:58 AM | Amylyx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/09/2023
6:07 AM | Amylyx Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/02/2023
2:33 PM | Amylyx Pharmaceuticals (Issuer)
FRATES JAMES M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Gold Set to EXPLODE! (Ad) Gold has already reached all-time highs, and experts believe it's not slowing down any time soon.
In fact, some analysts predict a $7,000 price tag by 2025. Click here now to download the free Precious Metals Buying Guide! |
10/13/2023
4:20 PM | Amylyx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/04/2023
3:19 PM | Amylyx Pharmaceuticals (Subject)
Morningside Venture Investments Ltd (Filed by)
| Form SC 13D/A | |
08/24/2023
3:15 PM | Amylyx Pharmaceuticals (Issuer)
FRATES JAMES M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/17/2023
4:34 PM | Amylyx Pharmaceuticals (Issuer)
Morningside Venture Investments Ltd (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/17/2023
4:15 PM | Amylyx Pharmaceuticals (Subject)
Morningside Venture Investments Ltd (Filed by)
| Form SC 13D/A | |
08/17/2023
3:35 PM | Amylyx Pharmaceuticals (Issuer)
Mazzariello Gina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/14/2023
3:20 PM | Amylyx Pharmaceuticals (Issuer)
Olinger Margaret (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
4:16 PM | Amylyx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/12/2023
6:50 PM | Amylyx Pharmaceuticals (Issuer)
Firestone Karen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2023
6:39 PM | Amylyx Pharmaceuticals (Issuer)
Quimi Daphne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2023
6:46 PM | Amylyx Pharmaceuticals (Issuer)
MILNE GEORGE M JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2023
6:34 PM | Amylyx Pharmaceuticals (Issuer)
FONTEYNE PAUL R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
7:14 AM | Amylyx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/24/2023
3:38 PM | Amylyx Pharmaceuticals (Issuer)
Olinger Margaret (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/18/2023
7:54 PM | Amylyx Pharmaceuticals (Issuer)
FRATES JAMES M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
